127 jobs found in Waltham, MA

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration....

We are seeking to hire a Precision Medicine Strategy Lead (PMSL) to oversee the development and execution of biomarker strategies for Regeneron Cell Medicines involving novel cell therapies and combinations with bispecific antibodies across multiple disease areas. In this highly matrixed role, they will design, develop, communicate across levels and operationally implement clinical biomarker strategies to support select programs in early and late stage drug development. Clinical biomarker assays include pharmacokinetic assays, patient stratification assays as well as immunology based pharmacodynamic assays. As a Director, a typical day may include the following: Program-level Precision Medicine lead for implementation of strategic vision for Pharmacokinetic and exploratory biomarkers in the clinic to enable indication and/or patient selection, early indication of biological activity and potential novel combinations. Collaborate with Biomarker and clinical operation teams...

We are seeking an enthusiastic Senior Associate Scientist to join our Analytical Innovation team as a part of our broader Regeneron Cell Medicines (RCM) group. You will join our Biomolecular Innovation group, which explores new molecular biology approaches to characterizing CAR-T cells and lentiviral vectors (LVVs) to further process and translational knowledge of our therapies. We hope you are excited to work collaboratively across functions to meet project milestones, with the goal to deliver therapies that transform the lives of patients. As a Senior Associate Scientist, a typical day might include: Assisting in the development of novel multiomic NGS workflows for CAR-T cell products and ddPCR assays for characterizing virus-like particles Preparing NGS libraries and ddPCR experiments Performing general laboratory tasks, including sequencer operation and maintenance of equipment Maintaining accurate and reliable records including electronic notebooks and all...

We are seeking a highly skilled and passionate Senior Scientist to support Regeneron Cell Medicine (RCM) mission to bring innovative cell therapy products to patients. This role will be critical to advance TCR- and CAR-based programs, as well as bring new ideas to improve our platforms and future programs. As a Senior Scientist, a typical day might include: Leveraging molecular biology techniques to design constructs, clone, and generate lentiviral vectors using proprietary platform technology Designing and carrying out experimental plans to functionally characterize TCR- and CAR-based T cell products through cell based assays and other relevant procedures to explore and validate novel cell therapy approaches. Maintaining detailed and timely records of experimental protocols, results, and observations. Identifying experimental challenges and collaborating with the team to troubleshoot technical issues and propose creative solutions to overcome obstacles....

We are seeking an enthusiastic Associate Director, Program & Portfolio Management to drive programs forward at Regeneron Cell Medicines (RCM) through collaborative leadership, providing clarity, direction and a shared sense of purpose to achieve amazing results for patients.  You will join our Program Strategy & Operations (PS&O) team, which oversees the portfolio of work and provides program management at RCM.  In this role, you’ll be a leader on cross-functional program teams (spanning research, clinical, CMC, quality, regulatory, finance, and alliance management) solving complex science and business challenges.  We hope you are excited to focus on programs that are in IND-enabling studies through clinical study execution. As an Associate Director, Program & Portfolio Management at RCM, a typical day might include: Collaborating with Strategic Program Teams to form and manage high-performing cross-functional teams, develop strategic and operational...

Job Title: Account Director, Specialty Pharmacy Networks (GPO, IDN & Limited Distribution) Location: Remote, US About the Job Account Director, Specialty Pharmacy Networks (GPO, IDN & Limited Distribution) The Account Director, Specialty Pharmacy Networks is responsible for leading contractual, and operational engagement across applicable Limited Distribution Networks (LDN), Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs), and select independent pharmacy partners across Specialty Care and General Medicines portfolios reporting to the Senior Director, Specialty Pharmacy Strategic & Limited Networks. This role serves as the lead for institutional customer engagement, and contracting execution, ensuring optimal product and patient access, financial performance, service delivery, data exchange, and overall patient experience across the distribution ecosystem. The role also leads GPO channel execution and serves as the Trade...

Job Title: Senior Manager, US Portfolio Marketing, Rare Blood Disorders Location: Cambridge, MA About the Role We are looking for a Senior Manager of US Portfolio Marketing that will develop and lead marketing projects and operations important to the success of the team. The Senior Manager, US Portfolio Marketing role reports to the Head, US Portfolio Marketing and will have a focus on the Hemophilia Franchise.  This role will be responsible for supporting a cohesive strategy across the team by working closely with internal and external stakeholders. Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. About Sanofi:  We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding...

Job Title Legal Counsel, North America Sales and Service (Cambridge, MA) Job Description In this role, you will be a key member of the Philips Legal Function, providing strategic legal support to Philips’ North America Sales and Service organization. Your primary responsibility will be to advise on a broad range of legal issues related to the sale and servicing of Philips’ medical devices and digital health solutions in the U.S. This includes navigating complex sales and technology transactions, as well as ensuring compliance with applicable laws and regulations. This is a high-impact, visible position where you will serve as a thought leader within the Legal Function, offering insights on evolving legal and market trends that influence Philips’ engagement with its U.S. customer base. You will regularly collaborate with stakeholders across all levels of the organization, including executive leadership, to deliver practical, business-oriented legal guidance. Your role:...

McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well-being of you and those we serve – we care. What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow’s health today, we want to hear from you. The Customer Success Executive (CSE) serves as the primary post-sale point of contact for cell, gene and advanced therapy (CGAT) clients ensuring continuity between the client and McKesson. They will use their in-depth knowledge of our biopharma partners, McKesson’s (CGAT) service lines (e.g., specialty pharmacy, 3PL, specialty distribution, Hub services, patient...

Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time. Responsibilities: Achievement of regional sales objectives; revenue and expenses. Development and execution of a regional and territory business plans. Direct execution of sales strategies and tactics, and implementation of sales and marketing plans. Develop and maintain key customer relationships with target audiences; assist in developing business solutions that are mutually beneficial; apply broader business scenarios and customer-focused models to achieve breakthrough results. Plan and conduct regional...

Job Summary Medline's ReNewal Division is hiring for a Part-Time Field Services Representative (15 hours/week) to cover the Massachusetts and New Hampshire territory! Medline ReNewal gets used medical devices and reprocesses them resulting in less waste in landfills and savings to facilities that buy reprocessed devices at a fraction of the original cost. Check out our video on YouTube to learn more about who we are! Video Link: https://www.youtube.com/watch?v=LsdpSjd1fYs Job Description Under the supervision of the Regional Manager and working in Massachusetts and New Hampshire, the Part-Time Field Services Representative (15 hours/week)  is responsible for the on-going support of the Medline ReNewal Reprocessing Program to pack and ship designated medical devices as well as execute any other tasks as agreed to with the facility. This individual will deliver prompt and excellent service to maintain and grow the program through job functions which include, but are not...